title: Biodegradable chitosan-based ambroxol hydrochloride microspheres: effect of cross-linking agents.
abstract: The objective of this study was to investigate the influence of type of cross-linking method used on the properties of ambroxol hydrochloride microspheres such as encapsulation efficiency, particle size, and drug release. Microspheres were prepared by solvent evaporation technique using chitosan as a matrix-forming agent and cross-linked using formaldehyde and heat treatment. Morphological and physicochemical properties of microspheres were then investigated by scanning electron microscopy (SEM), X-ray diffractometry (XRD), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FTIR) spectroscopy. The cross-linking of chitosan takes place at the free amino group because of formation of imine bond as evidenced by FTIR. The DSC, XRD, and FTIR analysis showed that chitosan microspheres cross linked by heating were superior in properties and performance as compared to the microspheres cross-linked using formaldehyde. SEM results revealed that heat-treated microspheres were spherical, discrete having smooth, and porous structure. The particle size and encapsulation efficiencies of the prepared chitosan microspheres ranged between 10.83-24.11 μm and 39.73μ80.56%, respectively. The drug release was extended up to 12 h, and the kinetics of the drug release was obeying Higuchi kinetic proving diffusion-controlled drug release.
authors: SNJB's Shriman Suresh Dada Jain College of Pharmacy, Neminagar, Chandwad, Nasik, Maharastra, India.
authors: Hh
authors: H
authors: Gangurde
authors: Nv
authors: N
authors: Chavan
authors: As
authors: A
authors: Mundada
authors: Dv
authors: D
authors: Derle
authors: S
authors: S
authors: Tamizharasi
references: Clin Ther. 2003 Aug;25(8):2225-32
references: 14512130
references: Drug Dev Ind Pharm. 2005 Aug;31(7):597-605
references: 16207606
references: Int J Pharm. 2004 Mar 1;271(1-2):233-40
references: 15129990
references: Pharmacol Res. 2004 Jan;49(1):93-8
references: 14597158
references: J Microencapsul. 1999 Nov-Dec;16(6):697-703
references: 10575622
references: J Microencapsul. 2002 Mar-Apr;19(2):173-80
references: 11837972
references: Int J Pharm. 2004 Apr 15;274(1-2):1-33
references: 15072779
references: Eur J Pharm Biopharm. 2006 Apr;62(3):295-305
references: 16314079
references: Int J Pharm. 2007 Apr 20;335(1-2):90-96
references: 17141988
references: Biomaterials. 1998 Jan-Feb;19(1-3):157-61
references: 9678863
references: Eur J Pharm Biopharm. 1999 Sep;48(2):149-55
references: 10469933
references: Int J Pharm. 2006 Jan 3;307(1):9-15
references: 16257156
references: Int J Pharm. 2006 Apr 7;312(1-2):166-73
references: 16497452